MICROBIOTIX

MicrobiotiX strives to develop treatments
 for global intractable diseases
such as multidrug-resistant
bacterial infections, autoimmune diseases and cancer

CDMO

Phage, Microbiome
& Beyond

CDMO SERVICE

01

We provide specialized service that includes: product development, process optimization for bacteriophage drugs developed by consigned companies, technology transfer, aseptic vial filling for the production of drugs for clinical trial and for the drugs which has gone through the clinical trials.

02

Our production capabilities and quality assurance system fully comply with Good Manufacturing Practice (cGMP) and global regulations to provide highest quality of the product.

03

MicrobiotiX is developing a treatment for intractable multidrug-resistant bacteria through bacteriophage R&D for more than 15 years. We provide consignment research and production services based on cGMP manufacturing facilities dedicated to bacteriophage and long-term R&D know-how.

Speed and Flexibility

MicrobiotiX complies with global regulations for the highest quality. We were also founded on the principle of delivering better CDMO services with speed and a competitive price. In line with this principle, microbiotix is trying to redefine the concept of what good customer satisfaction can be and provide the highest level of customer satisfaction, the likes of which the pharmaceutical industry has never seen before. We will provide reliable, high-quality services at all levels, from sterile filing and foreign contaminant inspection to packaging.

Aseptic filling

Small/Large commercial and clinical
vials and syringes
Biological and chemical formulations

Visual inspection
and packaging

Foreign body
Inspecting bulk packaging

Storage and shipping

Passive/active transport that can be stored from refrigerated (2-8°C ) to cryogenic (-70°C )

MICROBIOTIX CO., LTD

Severance Hospital Clinical Research Center #221   l   TEL : 02. 6379. 2649   l   E-mail : mx@microbiotix.net

Copyright © MICROBIOTIX. All rights reserved.

Privacy Policy     Prohibition of Unauthorized Email Collection